Eicosapentaenoic acid inhibits oxidation of ApoB-containing lipoprotein particles of different size in vitro when administered alone or in combination with atorvastatin active metabolite compared with other triglyceride-lowering agents

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

Generics substitution, bioequivalence standards, and international oversight: complex issues facing the FDA

Characterization of cholesterol crystalline domains in model and biological membranes using X-ray diffraction

Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes

Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells

Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes

Atorvastatin active metabolite inhibits oxidative modification of small dense low-density lipoprotein